Evidence map›Paper›PMID 42312939›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2026

Energy Balance-Related Factors and Direct Tumor-Adipocyte Contact in Colorectal Cancer: Etiologic Insights from the Population-Based Netherlands Cohort Study.

Kelly Offermans, Nic G Reitsam, Bianca Grosser, Jessica Zimmermann, Heike I Grabsch, Colinda C J M Simons, Piet A van den Brandt, Bruno Märkl

Abstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kelly OffermansDepartment of Epidemiology, Care and Public Health Research Institute (CAPHRI), Maastricht University Medical Center+, Maastricht, the Netherlands.ORCID 0000-0001-6842-4887
Nic G ReitsamPathology, Medical Faculty, University of Augsburg, Augsburg, Germany.ORCID 0000-0002-0070-3158
Bianca GrosserPathology, Medical Faculty, University of Augsburg, Augsburg, Germany.ORCID 0000-0003-4957-4876
Jessica ZimmermannPathology, Medical Faculty, University of Augsburg, Augsburg, Germany.ORCID 0009-0008-6733-5899
Heike I GrabschDepartment of Pathology, GROW-Research Institute for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands.ORCID 0000-0001-9520-6228
Colinda C J M SimonsDepartment of Epidemiology, GROW-Research Institute for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands.ORCID 0000-0002-0085-5186
Piet A van den BrandtDepartment of Epidemiology, Care and Public Health Research Institute (CAPHRI), Maastricht University Medical Center+, Maastricht, the Netherlands.ORCID 0000-0001-8781-8099
Bruno MärklPathology, Medical Faculty, University of Augsburg, Augsburg, Germany.ORCID 0000-0002-7704-850X

Funding

KWF Kankerbestrijding (KWF) KWF 11044
6 · The paper itself

Abstract

backgroundStroma AReactive Invasion Front Areas (SARIFA) are a histopathologic biomarker characterized by a direct tumor-adipocyte contact at the tumor invasion front. Although the tumor-promoting effect of tumor-adipocyte interactions has often been linked to obesity, it is unclear whether prediagnostic energy balance-related factors are differentially associated with the risk of SARIFA-positive versus SARIFA-negative colorectal cancers.

methodsWe analyzed data from the Netherlands Cohort Study, including 120,852 participants and 1,826 incident colorectal cancer cases with known SARIFA status. Multivariable-adjusted Cox regression was used to estimate associations between baseline prediagnostic body mass index (BMI), lower-body clothing size as a proxy for waist circumference, and nonoccupational physical activity and colon and rectal cancer risk by SARIFA status.

resultsIn men, BMI was more strongly associated with the risk of SARIFA-positive colon cancer [hazard ratio (HR) per 5 kg/m2, 1.57; 95% confidence interval (CI), 1.20-2.07] than SARIFA-negative tumors (HR, 1.22; 95% CI, 1.01-1.48), with similar patterns for lower-body clothing size. In women, weaker associations were observed, but estimates were again higher for SARIFA-positive tumors than SARIFA-negative tumors. Physical activity was inversely associated with SARIFA-positive colon cancer in women (HR per 30 minutes/day, 0.92; 95% CI, 0.85-1.01), but not SARIFA-negative tumors, with no clear SARIFA-specific patterns in men or for rectal cancer.

conclusionsFindings suggest a stronger role of body fatness in the development of SARIFA-positive than SARIFA-negative colon cancer and provide novel evidence warranting confirmation in other molecular pathologic epidemiology studies. IMPACT: This study extends previous epidemiologic findings by suggesting that adiposity may influence colon cancer development, resulting in a specific tumor-stroma interaction phenotype.

Indexed as

AdipocytesColorectal NeoplasmsEnergy MetabolismAgedBody Mass IndexCohort StudiesFemaleHumansMaleMiddle AgedNetherlandsObesityRisk Factors

Identifiers

PMID42312939
PMCPMC13530991

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.